Navigation Links
Study highlights need for coordination of care in stage 2 and 3 rectal cancer treatment
Date:5/15/2012

residence to look at how they may affect treatment patterns throughout the province.

Significant regional variation

Patients living in Edmonton were twice as likely to have a consultation with an oncologist after surgery as those living in Calgary or other parts of central or southern Alberta. Once a patient had a consult with an oncologist, however, region of residence was not associated with receiving chemotherapy.

"That points to the importance of co-ordination of care," added Winget.

Age was another factor, with 78 per cent of patients aged 75 and older not receiving treatment according to guidelines. Some 42 per cent were not referred to an oncologist.

"Just being 75 or older should not be a reason not to see an oncologist or not to get treatment. However, the data reflect the complexity in making treatment decisions in this age group," said Noha Sharaf El-din, a PhD candidate and co-author of the study.

Reasons for such results are likely multi-faceted, Sharaf El-din added. Older patients are more likely to have other diseases and ailments that could prevent them from being a candidate for chemotherapy. But even when factoring in other diseases, Winget's team found that age was still the largest factor in not receiving chemotherapy.

"The bottom line is there's variation in how individual oncologists perceive co-morbidities and age in a patient's ability to tolerate chemotherapy and be a chemo candidate," Winget said. "We wouldn't expect 100 per cent of rectal cancer patients to be medically eligible, but surely the number should be more than 50 per cent."

Winget said the overall results suggest that tighter co-ordination between surgeons and oncologists is needed, as is greater clarity regarding guidelines for colon and rectal cancer, which are similar diseases but are treated slightly differently.

She's taken the findings to the medical community to raise awareness and pro
'/>"/>

Contact: Bryan Alary
bryan.alary@ualberta.ca
780-492-0436
University of Alberta
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. 53 million Americans might have diabetes by 2025, according to a new study in Population Health Management
2. Study examines BI-RADS and MRI in predicting breast cancer
3. Self-Managing COPD Might Pose Risks, Study Suggests
4. Study finds number of battery-related emergency department visits by children more than doubles
5. UTSA study finds ovulating women perceive sexy cads as good dads
6. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
7. Button Batteries Sending More Kids to ER: Study
8. In Rat Study, Eye Device Shows Promise for Restoring Sight
9. Back Pain Therapy Often Yields Early Benefits: Study
10. Georgetown physician leads national resveratrol study for Alzheimers disease
11. New type of retinal prosthesis could better restore sight to blind, Stanford study says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... January 22, 2015 Compare-autoinsurance.org has released a new ... by an auto insurance policy . , Some types ... Clients should check the newly released blog post to see if ... and dangerously damaged vehicles are some of the cars that cannot ...
(Date:12/26/2014)... December 26, 2014 The US represents the ... report. In 2013, GlobalData’s forecast estimates that sales of branded ... market due to the high incidence of the disease, high ... 5EU, Japan, and China. Increased sales of CRC therapies over ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... PARK, N.J., Jan. 9 Managed Health Care,Associates, ... today,announced the addition of two outside members, Mr. ... MHA Board of Directors. Mr. Freedman and Mr.,Wheelan ... MHA,and Diamond Castle Holdings, LLC., Barry Freedman ...
... (OTC BB:ALRX -,News) stated on Tuesday that CEO Michael ... the open market, bringing the total number of,shares purchased ... confidence in the Company,s future., Mr. Michael Lee ... average price of $0.24 each, increasing his holdings to ...
... history of schizophrenia, social withdrawal among symptoms, study finds, , , ... to predict who will develop psychotic illnesses, such as schizophrenia ... new study says. , The study found five factors that ... disorder in children who were already at high risk of ...
... help simplify and refine search, SEATTLE, Jan. 9 ... an aging parent some adult children may be asking ... their loved ones., "That question often arises after ... said Eve Stern, RN, MS, president of,SNAPforSeniors, which has ...
... help employers, employees get more ... value from workplace benefits plans, COLUMBIA, S.C., ... has a new look -- and a clearer message.,Colonial Life ... tagline designed to better communicate who the company is and ...
... Jerusalem, Jan. 9. 2008 -- Two Hebrew University of ... have been awarded the 2008 Wolf Prize in Medicine ... expression and cancer research. , Minister of Education ... announced that the $100,000 prize, often referred to as ...
Cached Medicine News:Health News:MHA Announces: Managed Health Care Associates, Inc. (MHA) Expands Board of Directors 2Health News:MHA Announces: Managed Health Care Associates, Inc. (MHA) Expands Board of Directors 3Health News:5 Factors Help Predict Psychosis in Children 2Health News:5 Factors Help Predict Psychosis in Children 3Health News:Holiday Visits Nudge Many Towards Senior Housing Decision 2Health News:Holiday Visits Nudge Many Towards Senior Housing Decision 3Health News:Holiday Visits Nudge Many Towards Senior Housing Decision 4Health News:Holiday Visits Nudge Many Towards Senior Housing Decision 5Health News:New Colonial Life Brand Clarifies Company's Strengths 2Health News:New Colonial Life Brand Clarifies Company's Strengths 3Health News:2 Hebrew University scientists awarded Wolf Prizes 2
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today reported ... 31, 2014.  Global revenue for the Company,s ... million, a new quarterly revenue record, as compared to ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015  Profil Institute ... focused on diabetes and obesity, announced today a new ... Drug Development,  published by Springer, a leading global scientific ... extensively analyze and illustrate techniques for use in early ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... PARSIPPANY, N.J., July 7, 2011 Watson Pharmaceuticals, Inc. ... United States Court of Appeals for the Federal Circuit ... Southern District of Florida,s February 2011 decision that Watson,s ... Mucinex(R) DM (Dextromethorphan HBr/ Guaifenesin) Extended-Release products do not ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc., filed an Abbreviated New Drug Application ... (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. ... of Shire LLC,s Vyvanse®. Vyvanse® is a prescription ...
Cached Medicine Technology:Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit 2Watson Confirms Vyvanse® Patent Challenge 2
... from medium compression weight ... provides upper back compression ... the arms. Arm length ... Wonderfabric™ unraveling. Velcro® closing ...
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s...
This compression garment can be used for Breast Augmentation, Augmentation Mammaplasty, Trans Umbilical Breast Augmentation, Transaxillary Submuscular Augmentation....
Provides gentle compression above and below implants...
Medicine Products: